Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
BPI Contributor
May 1, 2012
1 Min Read
This conference offers solutions toward better industry cooperation in standards harmonization and downstream processing. New applications for disposables in fill–finish and bulk storage will be covered through a series of case studies, panel discussions, point–counterpoint debates, and breakout-discussion roundtables.
Program Highlights
PDA Task Force for Single-Use Systems will outline a technical report overview and concepts focused on extractables and leachables.
Genentech will disclose additional data from experiences with disposable bags for cell culture media storage.
A panel of experts from Millipore, Novasep, Repligen, and Pall will discuss vendor strategies to overcome bottlenecks in downstream processing.
Protein Sciences Corporation will espouse on pandemic preparedness and detail the manufacturing of an emergency vaccine, especially the role single-use systems can play.
Sanofi-Pasteur will assess the supply chain risk in single-use system implementation.
Human Genome Sciences will weigh the advantages and challenges of using disposable technology in fill–finish processes.
Keynotes
David J. Pollard (Merck & Co., Inc.) on extracting the full potential of single use
Robert Repetto (Pfizer BioTherapeutics) on sustainability of single-use technology and innovation
Peter Kraemer (Sanofi SA) on challenges and opportunities for manufacturing at an industrial scale with single-use components
Attend the colocated summit below at no extra charge. Find out more online atwww.IBCLifeSciences.com/singleuse.
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More